On September 12, 2023, Aaron Fletcher notified Cue Biopharma, Inc. (the ?Company?) of his decision to resign as a member of the Board of Directors of the Company (the ?Board?) and all committees thereof, effective on October 9, 2023.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.9402 USD | -0.85% |
|
-2.06% | -64.39% |
Jul. 01 | Cue Biopharma, Inc.(NasdaqCM:CUE) dropped from Russell 3000E Growth Index | CI |
Jul. 01 | Cue Biopharma, Inc.(NasdaqCM:CUE) dropped from Russell 2000 Growth Index | CI |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-64.39% | 45.73M | |
+20.12% | 126B | |
+25.25% | 119B | |
+25.56% | 27.95B | |
-19.51% | 20.5B | |
-14.36% | 17.12B | |
-15.63% | 16.1B | |
-46.67% | 14.97B | |
+11.89% | 14.84B | |
+57.74% | 14.38B |
- Stock Market
- Equities
- CUE Stock
- News Cue Biopharma, Inc.
- Cue Biopharma, Inc. Announces Resignation of Aaron Fletcher as Member of the Board of Directors, Effective October 9, 2023